Publication Name	World Journal of Clinical Oncology
Manuscript ID	90898
Country	Greece

Received	2023-12-16 20:48
Peer-Review Started	2023-12-16 20:48
To Make the First Decision
Return for Revision	2024-01-10 09:25
Revised	2024-01-23 11:41
Second Decision	2024-02-23 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-02-23 06:00
Articles in Press	2024-02-23 06:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-03-05 06:28
Publish the Manuscript Online	2024-03-22 11:48

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Editorial
Article Title	Approaches and challenges in cancer immunotherapy pathways
Manuscript Source	Invited Manuscript
All Author List	Maria Kapritsou
ORCID	Author(s) ORCID Number Maria Kapritsou http://orcid.org/0000-0002-8187-4978
Funding Agency and Grant Number
Corresponding Author	Maria Kapritsou, MSc, PhD, RN, Chief Nurse, Pathological Sector, Hellenic Anticancer Institute, "Saint Savvas" Hospital, Av Alexandras 171, Athens 11522, Greece. mariakaprit@gmail.com
Key Words	Immunotherapy; Oncological patients; Immune response; Target therapies; Cancer vaccinations
Core Tip	Immunotherapy has emerged as a potent treatment for specific cancer types, which evokes enduring reactions and sometimes even induces remission. Nevertheless, the efficiency of this method relies both on the type of malignancy involved and individual patient traits. Additionally, it is administered in tandem with surgical interventions or chemotherapy/radiation regimens. It holds promise but could not act as a panacea; ongoing studies focus on enhancing its efficacy levels while comprehending underlying mechanisms more precisely.
Publish Date	2024-03-22 11:48
Citation	Kapritsou M. Approaches and challenges in cancer immunotherapy pathways. World J Clin Oncol 2024; 15(3): 378-380
URL	https://www.wjgnet.com/2218-4333/full/v15/i3/378.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i3.378

Full Article (PDF)	WJCO-15-378-with-cover.pdf
Manuscript File	90898_Auto_Edited-YJP.docx
Answering Reviewers	90898-Answering reviewers.pdf
Audio Core Tip	90898-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	90898-Conflict-of-interest statement.pdf
Copyright License Agreement	90898-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90898-Language certificate.pdf
Peer-review Report	90898-Peer-review(s).pdf
Scientific Misconduct Check	90898-CrossCheck.png
Scientific Misconduct Check	90898-Bing-Gong ZM-2.png
Scientific Editor Work List	90898-Scientific editor work list.pdf
CrossCheck Report	90898-CrossCheck report.pdf